BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Nov 26, 2025; 17(11): 112484
Published online Nov 26, 2025. doi: 10.4252/wjsc.v17.i11.112484
HIF-1α modulates β-catenin pathway to enhance the survival and angiogenesis of PBMSCs under hypoxia environment
Peng-Zhen Wang, Ai-Qun Wang, Ping-Ge Tian, Ping-Ping Zhu, Wei Yuan, Jian Wu, Rui Zhang
Peng-Zhen Wang, Ping-Ping Zhu, Wei Yuan, Jian Wu, Guangzhou Institute of Traumatic Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou 510220, Guangdong Province, China
Ai-Qun Wang, Department of Anesthesiology, Guangzhou Red Cross Hospital of Jinan University, Guangzhou 510000, Guangdong Province, China
Ping-Ge Tian, Department of Cardiology, Guangzhou Red Cross Hospital of Jinan University, Guangzhou 510000, Guangdong Province, China
Rui Zhang, Department of Emergency, Guangzhou Red Cross Hospital of Jinan University, Guangzhou 510220, Guangdong Province, China
Co-first authors: Peng-Zhen Wang and Ai-Qun Wang.
Author contributions: Wang PZ, Wang AQ, Zhang R, Zhu PP, Yuan W, and Wu J performed all experiments; Wang PZ, Wang AQ, Tian PG, Zhu PP, and Yuan W participated in the data collection and data analysis; Wang PZ and Zhang R supervised the study and edited the manuscript; Wang PZ, Tian PG, and Zhang R acquired the funding. All the authors have read and approved the final manuscript. Wang PZ and Wang AQ contributed equally to this manuscript and are co-first authors.
Supported by Guangdong Provincial Natural Science Foundation General Program, No. 2025A1515012455; and Guangzhou Municipal Science and Technology Project, No. 2024A03J0653, No. 2023A03J0595, No. 2023A03J0510, and No. 2023A03J0528.
Institutional animal care and use committee statement: All animal experimental procedures were performed in adherence with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (revised 1996) and with the approval of the Animal Care and Use Committee of Guangzhou Red Cross Hospital (Approval No. 2023-027-1). All surgery and euthanasia were performed under sodium pentobarbital anesthesia (100 mg/kg) by intraperitoneal injection, and all efforts were made to minimize suffering. This study did not involve human subjects and human cells.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Data sharing statement: The datasets used or/and analyzed during the current study are available from the corresponding author on reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rui Zhang, MD, Chief Physician, Department of Emergency, Guangzhou Red Cross Hospital of Jinan University, No. 396 Tongfu Middle Road, Guangzhou 510220, Guangdong Province, China. 63281796@qq.com
Received: July 28, 2025
Revised: September 2, 2025
Accepted: October 9, 2025
Published online: November 26, 2025
Processing time: 120 Days and 19.2 Hours
Abstract
BACKGROUND

Stem cell therapy has been recognized as a promising strategy for enhancing cardiac function after myocardial infarction. Nonetheless, its clinical benefits are frequently limited by the poor survival and differentiation rates of the transplanted cells.

AIM

To clarify the role of hypoxia-inducible factor-1α (HIF-1α)/β-catenin in survival and angiogenesis of peripheral blood mesenchymal stem cells (PBMSCs).

METHODS

PBMSCs were isolated from rat abdominal aorta blood and characterized by multipotent differentiation assays. Cells were cultured under hypoxic conditions, followed by either overexpression or silencing of HIF-1α/β-catenin. Proliferative capacity was evaluated via colony formation assays, while cellular senescence was assessed using β-galactosidase staining. The protein and/or mRNA expressions of HIF-1α, β-catenin, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), survivin, Bcl2, Bax, cleaved caspase 3 were detected via western blotting and/or quantitative real-time polymerase chain reaction. PBMSCs co-expressing elevated HIF-1α and β-catenin levels were transplanted into infarcted myocardial tissue to evaluate their therapeutic potential in vivo.

RESULTS

HIF-1α or β-catenin overexpression enhanced self-renewal and inhibit apoptosis of PBMSCs by up-regulating Bcl2 and survivin, down-regulating Bax and cleaved-caspase 3. Besides, HIF-1α or β-catenin overexpression elevated angiogenesis via increasing bFGF and VEGF expressions. Silence of HIF-1α or β-catenin had opposite effect. Upregulation of HIF-1α increased β-catenin expression, whereas modifications in β-catenin did not influence HIF-1α expression. Chromatin immunoprecipitation assay verified that HIF-1α directly modulates β-catenin transcription. In vivo, HIF-1α overexpression significantly improved the retention of transplanted PBMSCs in infarcted myocardium and enhanced myocardial repair. Functional analysis further confirmed that HIF-1α operated through β-catenin, which directly modulated the expression of bFGF, VEGF, survivin, Bcl2, Bax and cleaved caspase 3, thereby coordinating the anti-apoptotic and pro-angiogenic functions of transplanted PBMSCs.

CONCLUSION

This study highlights the modulatory function of HIF-1α on PBMSCs via β-catenin-driven anti-apoptotic and angiogenic signaling cascade under hypoxia environment, offering a promising strategy for improving the therapeutic effectiveness PBMSCs-based transplantation after myocardial infarction.

Keywords: Angiogenesis; Hypoxia-inducible factor-1α; Myocardial infarction; Peripheral blood mesenchymal stem cells; β-catenin

Core Tip: The finding of this study indicates that hypoxia-inducible factor-1α (HIF-1α) and β-catenin facilitate peripheral blood mesenchymal stem cells (PBMSCs) self-renewal and inhibit PBMSCs apoptosis. In vivo, PBMSCs with upregulated HIF-1α achieved enhanced retention within infarcted myocardial and contributed markedly to myocardial regeneration. These observations highlight the modulatory role of HIF-1α in modulating PBMSCs function via β-catenin-dependent anti-apoptotic and pro-angiogenic pathway, thereby offering a potential strategy to improve the longevity and therapeutic efficacy of PBMSCs.